Hong Fang Song
Directeur/Bestuurslid bij CG ONCOLOGY, INC.
Vermogen: 22 M $ op 30-04-2024
Profiel
Hong Fang Song is an Independent Director at CG Oncology, Inc. and a Director at Enable Injections, Inc. She previously worked as a Managing Director at Cowen, Inc. She holds a graduate degree from Claremont Graduate University and an undergraduate degree from Fudan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.92% | 25-03-2024 | 613 928 ( 0.92% ) | 22 M $ | 30-04-2024 |
Actieve functies van Hong Fang Song
| Bedrijven | Functie | Begin |
|---|---|---|
| CG ONCOLOGY, INC. | Directeur/Bestuurslid | 01-11-2015 |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Hong Fang Song
| Bedrijven | Functie | Einde |
|---|---|---|
| COWEN INC. | Corporate Officer/Principal | - |
Opleiding van Hong Fang Song
| Fudan University | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm’s private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY. | Finance |